- Home
- PAC vs HOLX Comparison
PAC vs HOLX Comparison
Compare PAC & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAC
- HOLX
- Stock Information
- Founded
- PAC 1998
- HOLX 1985
- Country
- PAC Mexico
- HOLX United States
- Employees
- PAC N/A
- HOLX N/A
- Industry
- PAC Aerospace
- HOLX Medical Electronics
- Sector
- PAC Consumer Discretionary
- HOLX Health Care
- Exchange
- PAC Nasdaq
- HOLX Nasdaq
- Market Cap
- PAC 11.7B
- HOLX 16.5B
- IPO Year
- PAC 2006
- HOLX 1990
- Fundamental
- Price
- PAC $215.80
- HOLX $74.10
- Analyst Decision
- PAC Hold
- HOLX Hold
- Analyst Count
- PAC 5
- HOLX 15
- Target Price
- PAC $210.00
- HOLX $79.00
- AVG Volume (30 Days)
- PAC 83.7K
- HOLX 4.9M
- Earning Date
- PAC 10-20-2025
- HOLX 11-03-2025
- Dividend Yield
- PAC 5.21%
- HOLX N/A
- EPS Growth
- PAC 13.32
- HOLX N/A
- EPS
- PAC 1.07
- HOLX 2.49
- Revenue
- PAC $1,870,491,921.00
- HOLX $4,100,500,000.00
- Revenue This Year
- PAC $58.23
- HOLX $6.23
- Revenue Next Year
- PAC $7.61
- HOLX $5.37
- P/E Ratio
- PAC $20.21
- HOLX $29.76
- Revenue Growth
- PAC 35.46
- HOLX 1.74
- 52 Week Low
- PAC $168.62
- HOLX $51.90
- 52 Week High
- PAC $259.33
- HOLX $80.75
- Technical
- Relative Strength Index (RSI)
- PAC 42.84
- HOLX 70.04
- Support Level
- PAC $206.91
- HOLX $73.86
- Resistance Level
- PAC $222.95
- HOLX $74.28
- Average True Range (ATR)
- PAC 5.67
- HOLX 0.25
- MACD
- PAC 1.09
- HOLX -0.05
- Stochastic Oscillator
- PAC 57.91
- HOLX 29.07
About PAC Grupo Aeroportuario Del Pacifico
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.